Gilead Sciences Inc Congressional Trading
According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 295 trades in Gilead Sciences Inc (NASDAQ: GILD) since 2012, across 59 members, worth an estimated $4.3M in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 165 buys against 130 sells, a modestly buy-led skew, with Democratic members responsible for 34% of the trades and Republican members 66%. The most recent disclosure shown was filed August 2026, and Rohit Khanna has filed the most GILD transactions among those shown, with 7. Other recent filers include Jared Moskowitz, Alan Armstrong, and Josh Gottheimer. One notable disclosed move was a purchase by Rohit Khanna on May 15, 2026, up 14.8% since. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the Gilead Sciences Inc (GILD) stock overview and the complete trade table below.
Data updated
Price & congressional trade timeline
Party breakdown
Gilead Sciences congressional trading activity
| Politician | Published | Traded | Filed After | Type | Size | Return | Owner | |
|---|---|---|---|---|---|---|---|---|
 Rohit Khanna House | Aug 7, 2026 | Jul 20, 2026 | 18 days | BUY |  $1,001 - $15,000 | +11.68% | Spouse | |
Rohit Khanna House | Aug 7, 2026 | Jul 7, 2026 | 31 days | SELL | $1,001 - $15,000 | +9.10% | Child | |
Rohit Khanna House | Jul 6, 2026 | Jun 16, 2026 | 20 days | SELL | $15,001 - $50,000 | +16.93% | Spouse | |
Rohit Khanna House | Jun 9, 2026 | May 15, 2026 | 25 days | BUY | $15,001 - $50,000 | +14.81% | Spouse | |
 Jared Moskowitz House | Jun 19, 2026 | May 6, 2026 | 44 days | BUY | $1,001 - $15,000 | +9.15% | Child | |
Jared Moskowitz House | Jun 19, 2026 | May 6, 2026 | 44 days | BUY | $1,001 - $15,000 | +9.15% | Self | |
Rohit Khanna House | May 11, 2026 | Apr 13, 2026 | 28 days | SELL | $15,001 - $50,000 | +7.01% | Spouse | |
 Alan Armstrong Senate | Jul 21, 2026 | Mar 27, 2026 | 116 days | BUY | $1,001 - $15,000 | +10.82% | Self | |
Rohit Khanna House | Feb 6, 2026 | Jan 29, 2026 | 8 days | BUY | $15,001 - $50,000 | +7.21% | Spouse | |
 Josh Gottheimer House | Feb 26, 2026 | Jan 27, 2026 | 30 days | BUY | $1,001 - $15,000 | +6.13% | Joint |
Gilead Sciences (GILD) congressional trading FAQ
Can members of Congress legally trade Gilead Sciences (GILD) stock?
Yes. Members of Congress are permitted to trade individual stocks, including Gilead Sciences (GILD), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; it does not imply any trade was improper.
Are congressional Gilead Sciences (GILD) trades public?
Yes. Every congressional trade in Gilead Sciences (GILD) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.
How many times has Congress traded Gilead Sciences (GILD)?
Members of Congress have disclosed 295 trades in Gilead Sciences (GILD) worth $4.3M across 59 members, according to public STOCK Act filings.
Which members of Congress have traded Gilead Sciences (GILD)?
Recent and active filers of Gilead Sciences (GILD) disclosures include Rohit Khanna, Jared Moskowitz, Alan Armstrong. The full member-by-member trade list is on this page.
Do Democrats or Republicans trade Gilead Sciences (GILD) more?
Across disclosed Gilead Sciences (GILD) trades, 34% were by Democrats and 65% by Republicans, led by Republicans (65%).
What is the most recent congressional Gilead Sciences (GILD) trade?
The most recent disclosed Gilead Sciences (GILD) trade was a sale by Rohit Khanna, filed Aug 6, 2026.
Browse all stocks Congress tradesCongressional trading overviewGilead Sciences (GILD) stock overview
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.